Herpesvirus Saimiri Transformation of HIV Type 1 Suppressive CD8+Lymphocytes from an HIV Type 1-Infected Asymptomatic Individual
- 10 April 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 14 (6), 521-531
- https://doi.org/10.1089/aid.1998.14.521
Abstract
CD8+ T lymphocytes from HIV+ individuals can potently suppress HIV-1 replication in a noncytolytic manner. This suppression appears to be multifactorial and the molecules contributing have not been fully elucidated. As an approach to this question we used herpesvirus saimiri (HVS) to transform CD8+ T lymphocytes from an HIV+ asymptomatic donor to a continuously growing, activation-independent, IL-2-dependent phenotype. The transformed cell population, termed CD8(HVS), had an activated phenotype, contained HVS sequences, did not shed infectious HVS virus, and was polyclonal. The CD8(HVS) cells, despite the absence of detectable CTL activity, potently suppressed HIV-1 production by both autologous and heterologous CD4+ cells from infected donors. The CD8(HVS) cells in coculture also suppressed virus production from PBMCs acutely infected with syncytium-inducing (SI) strains or NSI primary isolates of HIV-1. The supernatants from the CD8(HVS) cells and their concentrates derived from these supernatants were suppressive to NSI primary isolates of HIV-1 but not to SI strains. Fractionation of these concentrates showed that the suppressive activity was associated with low molecular mass (6500- to 19,300-Da) protein species. Western blotting and ELISA indicated that the CC chemokines MIP-1α, MIP-1β, and RANTES were present in these fractions. Antibody-blocking studies with antibodies to the CC chemokines indicated that a significant portion of the soluble HIV-suppressive activity was due to these molecules. However, these experiments also suggested the inhibitory activity of the CD8(HVS) cells in coculture is not due exclusively to the CC chemokines. The HVS-transformed cells provide a useful tool for the study of noncytolytic CD8+ T lymphocyte-mediated suppression of HIV-1.Keywords
This publication has 58 references indexed in Scilit:
- Derivation ofHerpesvirus saimiri-Transformed CD8+T Cell Lines with Noncytotoxic Anti-HIV ActivityClinical Immunology and Immunopathology, 1997
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesCell, 1996
- Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cellsImmunology Today, 1996
- Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of diseaseClinical and Experimental Immunology, 1994
- CD8+T Lymphocyte-Mediated Inhibition of HIV-1 Long Terminal Repeat Transcription: A Novel Antiviral MechanismAIDS Research and Human Retroviruses, 1993
- Detection of HIV-1 DNA and Messenger RNA in Individual Cells by PCR-Driven in Situ Hybridization and Flow CytometryScience, 1993
- Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primatesClinical and Experimental Immunology, 1993
- CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency virusesCellular Immunology, 1991
- Plasma Viremia in Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989